相关实验视频
Updated: Jun 27, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
[患有转移性黑色素瘤的白血病反应的患者对恩科拉费尼布加比尼米丁尼布的剧烈反应.]
Marianna Cerro1, Maria Teresa Maccallini1, Michelangelo Russillo2
1Sapienza Università di Roma.
Recenti progressi in medicina
|May 6, 2024
概括
瘤性白血病反应 (PLR) 是一种罕见的黑色素瘤并发症. 用BRAF和MEK抑制剂进行向治疗,在患有BRAF V600E突变转移性黑色素瘤和PLR的患者中显示出有希望的结果.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 血液学 血液学 血液学
背景情况:
- 瘤性白血病反应 (PLR) 是一种罕见且往往在黑色素瘤患者中观察到的预后不利的疾病.
- BRAF突变分析对于管理不可手术或转移性黑色素瘤至关重要,指导向性治疗选择.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

